Member Info for passiton

Only 27m shares in total as TR-1 holder taken almost a quarter, 52wk high 61p
so few shares will move very very quickly if the masses arrive.

Sam the latest news alone if they get approval like sng did to bypass the normal regulations FDA fast track
could go anywhere , as inhaler news was good but now to also combat the virus in addition is huge
out of all the covid's in play only HEMO and TILS are targeting the virus itself, all else is just tests or treatment
of the symptoms sure others will come out of the woodwork with whole world on covids case but at the
moment we are one of those that could help NOW if live trials implemented like with sng

and the RNA state AIM cancellation DELAYED

suggests still plan to do so at some future time to a standard Nasdaq listing as NQ ADS also
to go from what I read

same with Nasdaq was 50 day ave sub 30k shares after the march and recent nq 75m v aim 15m trading
that 50 day ave on Nq is the equivalent of 3.4m per day

have two lots one a free ride after march breakout to £1.55 sadly sliced at £1.25 from 52p
2nd not so good when though it was gonna go again when it took off spiked myself
at 83p so across the total shares just under 41p

Not a vaccine but could do that also,, they like other diseases they are working on with success (lukemia)
they want to produce antibodies to put in a treatment (cure) that could be injected into INFECTED
patients, like sending in the antibody SAS to kick covid arse
A vaccine works by introduction of modified markers to provoke a reaction in the bodies immune system
resulting in the creation of antibodies and should give protection in the future
Vaccines are also less effective with age and in those with compromised immune systems (covid danger groups)
so may not provide some with enough or even any immunity.

Think the London spread has been deliberate for the past month, to prevent London running away
into the distance, while Nasdaq $2-75-$3.45 rangebound 44-55p the plan was for tils to bin AIM
this quarter, many say cancelled, the rna states DELAYED
It would seem Nasdaq as was planned, lording it over London despite AIM technically still being
the primary listing.
Until they finish faffing about with whatever is going on in the background and they release the
brakes or that blockbuster RNA lands, we continue to wait frustrated at muted response to news
so far GLA

The latest development by Hemo is they have been using as they call them HUMANISED MICE
in simple terms they have manipulated the rna/dna of the laboratory mice so in theory they
have a structure aligned to our own, therefore if things work and are safe in the mice they
should also work in the same manner in humans
Antibodies created in the mice from covid testing should be effective when then injected into
humans

WHO requested sng fast track their inhaler drug earlier in the crisis which is now being done used live
on patients at 10 locations across UK, FDA have slashed the rule book and so now hoping FDA also
fast track TILS/TLSA to do the same in American Hospitals in dire need of treatments, if proves to be
a success, pretty sure FDA/POTUS will throw everything at it for mass production

We had news Friday and Monday and more to follow but has not moved on the NASDAQ since last months
placing held range bound $2.75- $3.45 much lower than in London.
Until whatever is going on in the background ends it appears we will not be moving, should be one hell of
a bounce from this coiled spring once the brakes do come off. GLA

Main Market

w/w at least 3 global pharms already on various projects

Now entered the covid arena with potential treatment( cure) AB's to attack the virus
not just treatment of the body over reaction symptoms

The biggest if it cracks the antibody treatment (cure) direct injection of antibodies to kill the virus
as if you had an instant working vaccine
The tests will only ever help limit or slow down the volume of infected it will never stop you getting
it and certainly not help on your way to icu
This company could do the lot a test a vaccine and a holy grail antibody treatment that will prevent
so many dying in icu

NOT A TEST read the original, just like they did with lukemia etc they are to create antibodies for a treatment/CURE
create ANTIBODIES not test if you have them which they could also do. The big deal is if they can do this then inject
antibodies into infected patients, it would attack the virus

Prior to the appearance of COVID-19, Hemogenyx had been working independently and with a number of pharmaceutical company partners to utilize the exceptional features of ApbHC to identify and isolate human neutralizing antibodies for use as antiviral therapies.

At least only 30 minutes now to find out the USA Nasdaq reaction to the newS
fingers crossed Elsa will be screaming LET IT GO LET IT GO !!!!

Medical journal quotes on sng also inhaler, they are expecting the inhaler drugs to be 5 to 10 times
more effective due to going directly to the lungs
The iv/inject drug versions of interferon and il6 inhibitors have had some good success in China
and deployed to at least Italy spain and Pakistan since BUT they take time to build up in the system
The quicker method should speed up recovery rates and decrease the numbers progressing to the
icu sedated/ventilator 50/50 death stage, saving many many lives.

As the word spreads they will all want in for the prospect of a treatment (cure) for the virus
no one else is targeting the virus directly, all others are to treat symptoms created by it
so that the immune system can fight back and kill it
World needs something quick, that will improve your chances of avoiding 50/50 ICU
death lottery.
If they can then use as a model to replicate for NEW virus in the future BINGO

Yes Shukan
That would really put the wind in the sails

covid antibodies is a treatment/cure not a vaccine, although it could potentially double up
as an instant vaccine
vaccines are modified harmless markers used to trick the body into a response and thus create
antibodies to hopefully prevent future infection. Downside the older you get or other problems
the leff efficient your immune system becomes (covid in danger groups) and may or may not
give you the level of immunity required.
This is going to contain the antibodies ALREADY, so akin to sending the SAS in on the virus to kill it
so can treat infected patients directly and/or they could also use as an instant vaccine
With plans to develop further for possible as yet unknown virus threats, this could end up a world
leading Pharm if not taken out by a Global Giant

WHY
we released 2 big pieces of news recently and market is responding , now seller appears to be
cleared

and my apologies using the old laptop today and the nice tidy text typed, it does like to throw
asunder on posting